high-efficacy injectable therapies reserved for intensive intervention
According to a 2024 Kaiser Family Foundation survey, one in eight American adults said they have tried Ozempic or similar drugs in this new class of treatmentsincluding Wegovy, Zepbound, and Mounjaro
The prior authorization requirements differ for children (ages 12+) taking Wegovy for weight loss, as well as adults taking Wegovy to reduce their cardiovascular risk
And if you need help building a plan based on the realities of your life and tweaking and adjusting it as you go along, reach out
doi: 10.1016/j.cell.2018.09.055 25 de MelloVDPaananenJLindstromJLankinenMAShiLKuusistoJet al
[DOI] [PubMed] [Google Scholar] 93.Chen WR, Hu SY, Chen YD, Zhang Y, Qian G, Wang J, et al